The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor
Open accessAbstract
Hepatocyte growth factor/scatter factor (HGF/SF) is a mesenchymally derived, multifunctional paracrine regulator possessing mitogenic, motogenic, and morphogenetic activities in cultured epithelial cells containing its tyrosine kinase receptor, Met. c- met has been implicated in oncogenesis through correlation of expression with malignant phenotype in specific cell lines and tumors. Paradoxically, however, HGF/SF can also inhibit the growth of some tumor cells. To elucidate the oncogenic role of HGF/SF in vivo , transgenic mice were created such that HGF/SF was inappropriately targeted to a variety of tissues. HGF/SF transgenic mice developed a remarkably broad array of histologically distinct tumors of both mesenchymal and epithelial origin. Many neoplasms arose from tissues exhibiting abnormal development, including the mammary gland, skeletal muscle, and melanocytes, suggesting a functional link between mechanisms regulating morphogenesis and those promoting tumorigenesis. Most neoplasms, especially melanomas, demonstrated overexpression of both the HGF/SF transgene and endogenous c- met , and had enhanced Met kinase activity, strongly suggesting that autocrine signaling broadly promotes tumorigenesis. Thus, subversion of normal mesenchymal–epithelial paracrine regulation through the forced misdirection of HGF/SF expression induces aberrant morphogenesis and subsequent malignant transformation of cells of diverse origin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Self-citationScatter factor/hepatocyte growth factor is essential for liver development
Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., & Birchmeler, C. (1995) · Nature · doi:10.1038/373699a0 · Cited by 1,394
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284
Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor
Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., & Kitamura, N. (1995) · Nature · doi:10.1038/373702a0 · Cited by 1,041
Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., & Merlino, G. T. (1990) · Cell · doi:10.1016/0092-8674(90)90076-q · Cited by 710
Self-citationSonnenberg, E., Meyer, D., Weidner, K. M., & Birchmeier, C. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.1.223 · Cited by 698
The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.
Zarnegar, R., & Michalopoulos, G. K. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.5.1177 · Cited by 569
Mechanism of met oncogene activation
Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G., & Vande Woude, G. F. (1986) · Cell · doi:10.1016/0092-8674(86)90564-7 · Cited by 560
Expression of the Met/HGF receptor in normal and neoplastic human tissues.
Renzo, M. F. D., Narsimhan, R. P., Olivero, M., Bretti, S., Giordano, S., Médico, E., Gaglia, P., Zara, P., & Comoglio, P. M. (1991) · PubMed · Cited by 474
Renzo, M. F. D., Olivero, M., Giacomini, A., Porte, H., Chastre, E., Mirossay, L., Nordlinger, B., Bretti, S., Bottardi, S., & Giordano, S. (1995) · PubMed · Cited by 471
Rong, S., Segal, S., Anver, M., Resau, J. H., & Vande Woude, G. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4731 · Cited by 363
Self-citationFrequent amplification of the c-met gene in scirrhous type stomach cancer
Kuniyasu, H., Yasui, W., Kitadai, Y., Yokozaki, H., Ito, H., & Tahara, E. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91548-5 · Cited by 328
Hepatocyte growth factor: a multifunctional cytokine
Boros, P., & Miller, C. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90279-1 · Cited by 319
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
Renzo, M. F. D., Olivero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Costantino, A., Vigneri, R., & Pierotti, M. A. (1992) · PubMed · Cited by 312
Yang, Y., Spitzer, E., Meyer, D., Sachs, M., Niemann, C., Hartmann, G., Weidner, K. M., Birchmeier, C., & Birchmeier, W. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.1.215 · Cited by 300
Yamashita, J.-I., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T., & Shin, S.-I. (1994) · PubMed · Cited by 298
Brinkmann, V, Foroutan, H., Sachs, M., Weidner, K. M., & Birchmeier, W. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.6.1573 · Cited by 296
Prat, M., Narsimhan, R. P., Crepaldi, T., Rita Nicotra, M., Natali, P. G., & Comoglio, P. M. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490302 · Cited by 287
Ferracini, R., Renzo, M. F. D., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., & Comoglio, P. M. (1995) · PubMed · Cited by 280
Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction.
Rosen, E. M., Nigam, S. K., & Goldberg, I. D. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.1783 · Cited by 277
Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells.
Shiota, G., Rhoads, D. B., Wang, T. C., Nakamura, T., & Schmidt, E. V. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.373 · Cited by 251
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck, A. B., Park, M., Sterns, E. E., Boag, A., & Elliott, B. E. (1996) · Europe PMC (PubMed Central) · Cited by 244
Soriano, J. V., Pepper, M. S., Nakamura, T., Orci, L., & Montesano, R. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.2.413 · Cited by 232
Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.
Gherardi, E., & Stoker, M. G. P. (1991) · PubMed · Cited by 232
The Met Proto-Oncogene Mesenchymal to Epithelial Cell Conversion
Tsarfaty, I., Rong, S., Resau, J. H., Rulong, S., da Silva, P. P., & Vande Woude, G. F. (1994) · Science · doi:10.1126/science.7505952 · Cited by 211
Palmiter, R. D., Sandgren, E. P., Koeller, D. M., & Brinster, R. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5266 · Cited by 209
Natali, P., Nicotra, M., Di Renzo, M., Prat, M., Bigotti, A., Cavaliere, R., & Comoglio, P. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.422 · Cited by 205
Hepatocyte growth factor has potent anti‐proliferative activity in various tumor cell lines
Tajima, H., Matsumoto, K., & Nakamura, T. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81291-f · Cited by 199
Takayama, H., La Rochelle, W. J., Anver, M., Bockman, D. E., & Merlino, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5866 · Cited by 195
Self-citationHGF/SF: a potent cytokine for mammary growth, morphogenesis and development
Niranjan, B., Buluwela, L., Yant, J., Perusinghe, N., Atherton, A., Phippard, D., Dale, T., Gusterson, B., & Kamalati, T. (1995) · Development · doi:10.1242/dev.121.9.2897 · Cited by 170
Bellusci, S., Moens, G., Gaudino, G., Comoglio, P. M., Nakamura, T., Thiery, J. P., & Jouanneau, J. (1994) · PubMed · Cited by 168
Boccaccio, C., Gaudino, G., Gambarotta, G., Galimi, F., & Comoglio, P. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99953-9 · Cited by 160
Sakata, H., Takayama, H., Sharp, R., Rubin, J. S., Merlino, G. T., & LaRochelle, W. J. (1996) · PubMed · Cited by 153
Self-citationAndermarcher, E., Surani, M. A., & Gherardi, E. (1996) · Developmental Genetics · Cited by 130
Ferracini, R., Olivero, M., Renzo, M. F. D., Martano, M., Giovanni, C. D., Nanni, P., Basso, G., Scotlandi, K., Lollini, P., & Comoglio, P. M. (1996) · PubMed · Cited by 122
Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene.
Iyer, A., Kmiecik, T. E., Park, M., Daar, I. O., Blair, D. G., Dunn, K., Sutrave, P., Ihle, J. N., Bodescot, M., & Woude, G. V. (1990) · PubMed · Cited by 118
Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.
Liang, T. J., Reid, A. E., Xavier, R. J., Cardiff, R. D., & Wang, T. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118744 · Cited by 115
Characterization of the mouse met proto-oncogene.
Chan, A. M.-L., Hw, K., Deakin, E. A., Pr, T., Hilkens, J., Kroezen, V., Edwards, D. R., Aj, W., Brookes, P., & Cs, C. (1988) · PubMed · Cited by 109
Amundadottir, L. T., Johnson, M. D., Merlino, G. T., Smith, G. H., & Dickson, R. B. (1995) · PubMed · Cited by 90
Self-citationTakagi, H., Sharp, R., Hammermeister, C. L., Goodrow, T. L., Bradley, M. O., Fausto, N., & Merlino, G. T. (1992) · PubMed · Cited by 84
Self-citationDetection of the c‐met proto‐oncogene product in normal skin and tumours of melanocytic origin
SAITOH, K., Takahashi, H., Sawada, N., & Parsons, P. G. (1994) · The Journal of Pathology · doi:10.1002/path.1711740308 · Cited by 57
Rong, S., Donehower, L. A., Hansen, M. F., Strong, L. C., Tainsky, M. A., Jeffers, M., Resau, J., Hudson, E., Tsarfaty, I., & Woude, G. F. V. (1995) · PubMed · Cited by 54
Characterization of the Rearranged tpr-met Oncogene Breakpoint
Dean, M. C., Park, M., & Woude, G. F. V. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.921-924.1987 · Cited by 53
The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis
Cortner, J., Woude, G. F. V., & Rong, S. (1995) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9070-0_6 · Cited by 49
Tyrosine kinase receptors in the control of epithelial growth and morphogenesis during development
Birchmeier, C., Sonnenberg-Riethmacher, E., Weidner, K. M., & Walter, B. (1993) · BioEssays · doi:10.1002/bies.950150307 · Cited by 41
Pathology and Incidence of Amelanotic Melanomas of the Skin in F-344/N Rats
Yoshitomi, K., Elwell, M. R., & Boorman, G. A. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300103 · Cited by 18
Cited by
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Yakes, F. M., Chen, J., Tan, J., Yamaguchi, K., Shi, Y., Yu, P., Qian, F., Chu, F., Bentzien, F., Cancilla, B., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0264 · Cited by 1,336
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Comoglio, P. M., Giordano, S., & Trusolino, L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2530 · Cited by 818
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
Trusolino, L., & Comoglio, P. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc779 · Cited by 745
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
Ueki, T., Kaneda, Y., Tsutsui, H., Nakanishi, K., Sawa, Y., Morishita, R., Matsumoto, K., Nakamura, T., Takahashi, H., Okamoto, E., et al. (1999) · Nature Medicine · doi:10.1038/5593 · Cited by 587
Metadata
- Authors
- Takayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., & Merlino, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-01-21
- Volume
- 94
- Issue
- 2
- Pages
- 701-706
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2087352606
- Cited by
- 440
- References
- 46
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.